Sam Altman Has Explored Deal to Build a Rocket Company
Plus: A group of former FDA commissioners has criticized the agency’s new vaccine standards, citing risks to public health. And UBS says the world has more billionaires than ever. Daniel Bach hosts. Sign up for WSJ’s free What’s News newsletter.
Sam Altman Has Explored Deal to Build a Rocket Company
Plus: A group of former FDA commissioners has criticized the agency’s new vaccine standards, citing risks to public health. And UBS says the world has more billionaires than ever. Daniel Bach hosts. Sign up for WSJ’s free What’s News newsletter.